Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 3NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Genitourinary 1CNS 1

Conditions

Prostatic Neoplasms 1Oligodendroglioma 1Glioma 1Carcinoma, Non-Small-Cell Lung 1Astrocytoma 1

Interventions

Specimen Handling 84Magnetic Resonance Spectroscopy 83Cyclophosphamide 77pembrolizumab 64Radiotherapy 58Nivolumab 55fludarabine 47Cisplatin 45Biopsy 41Carboplatin 40Standard of Care 36Dexamethasone 33Rituximab 30Radiation 30Bevacizumab 30Radiosurgery 29Temozolomide 28Gemcitabine 28Surveys and Questionnaires 27Doxorubicin 27Cytarabine 27Paclitaxel 26venetoclax 25fludarabine phosphate 25Blood Specimen Collection 25Practice Guidelines as Topic 24Ipilimumab 24Interviews as Topic 21Fluorouracil 21atezolizumab 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Protons × 30 days × Clear all
NCT04190446 2026-06-04

A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer

Mayo Clinic

Phase 2 Active not recruiting
84 enrolled
Genitourinary

Prostatic Neoplasms

NCT03180502 2026-05-26

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

NRG Oncology

Phase 2 Active not recruiting
120 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma

NCT02444741 2026-05-15

Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

M.D. Anderson Cancer Center

Phase 1/2 Completed
124 enrolled 15 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡